Journal article · 2026 · Open access

Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort study

Amanda C Miles, Jelena Vojicic, Paula Peyrani, Summer Rosenstock, H Li, Jeffrey Vietri, Yan Qi, Alison E. Randall, Xin Zhao, Wencheng Zhu, Bobby Zhao, Anan Zhou and 7 more

The Lancet Infectious Diseases, 26(8), 807–818 · Published 30 April 2026 · DOI 10.1016/s1473-3099(26)00115-5

Open full textView at the publisherCite this paper

In brief

“Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort study” is a 2026 journal article by Amanda C Miles and 18 co-authors, published in The Lancet Infectious Diseases. OpenAlex counts 17 citations as of 17 November 2026, which puts it in the top 1% of works published in 2026 by citations. It is open access: the full text is free to read at SSRN Electronic Journal.

Citations
17
Most cited in
2026 (17)
Field-weighted impact
46.59
References
24
Authors
19

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Miles, A. C., Vojicic, J., Peyrani, P., Rosenstock, S., Li, H., Vietri, J., Qi, Y., Randall, A. E., Zhao, X., Zhu, W., Zhao, B., Zhou, A., Jódar, L., Gessner, B. D., Theilacker, C., Moïsi, J. C., Balmer, P., Grant, L. R., & Cane, A. D. (2026). Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort study. The Lancet Infectious Diseases, 26(8), 807–818. https://doi.org/10.1016/s1473-3099(26)00115-5

MLA 9

Miles, Amanda C, et al. “Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort study.” The Lancet Infectious Diseases, vol. 26, no. 8, 2026, pp. 807–818. https://doi.org/10.1016/s1473-3099(26)00115-5.

Chicago

Miles, Amanda C, Jelena Vojicic, Paula Peyrani, Summer Rosenstock, H Li, Jeffrey Vietri, Yan Qi, et al. 2026. “Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort study.” The Lancet Infectious Diseases 26 (8): 807–818. https://doi.org/10.1016/s1473-3099(26)00115-5.

Harvard

Miles, A. C. et al. (2026) ‘Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort study’, The Lancet Infectious Diseases, 26(8), pp. 807–818. doi:10.1016/s1473-3099(26)00115-5.

IEEE

A. C. Miles et al., “Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort study,” The Lancet Infectious Diseases, vol. 26, no. 8, pp. 807–818, 2026, doi: 10.1016/s1473-3099(26)00115-5.

BibTeX

@article{miles2026real,
  title     = {{Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort study}},
  author    = {Miles, Amanda C and Vojicic, Jelena and Peyrani, Paula and Rosenstock, Summer and Li, H and Vietri, Jeffrey and Qi, Yan and Randall, Alison E. and Zhao, Xin and Zhu, Wencheng and Zhao, Bobby and Zhou, Anan and Jódar, Luis and Gessner, Bradford D. and Theilacker, Christian and Moïsi, Jennifer C. and Balmer, Paul and Grant, Lindsay R. and Cane, Alejandro D.},
  journal   = {The Lancet Infectious Diseases},
  year      = {2026},
  volume    = {26},
  number    = {8},
  pages     = {807--818},
  doi       = {10.1016/s1473-3099(26)00115-5},
  url       = {https://doi.org/10.1016/s1473-3099(26)00115-5}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Epidemiology › Pneumonia and Respiratory Infections

  • PCV20
  • vaccine effectiveness
  • invasive pneumococcal disease
  • pneumococcal pneumonia
  • all-cause pneumonia
  • lower respiratory tract infection
  • older adults
  • Medicare beneficiaries

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Miles, A. C., Vojicic, J., Peyrani, P., Rosenstock, S., Li, H., Vietri, J., Qi, Y., Randall, A. E., Zhao, X., Zhu, W., Zhao, B., Zhou, A., Jódar, L., Gessner, B. D., Theilacker, C., Moïsi, J. C., Balmer, P., Grant, L. R., & Cane, A. D. (2026). Real-world effectiveness of 20-valent pneumococcal conjugate vaccine against all-cause outcomes among Medicare beneficiaries aged 65 years and older in the USA: a retrospective cohort study. The Lancet Infectious Diseases, 26(8), 807–818. https://doi.org/10.1016/s1473-3099(26)00115-5

How many times has this paper been cited?

17 times, according to OpenAlex on 17 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

Yes. It is open access at SSRN Electronic Journal: sign in and open the full text from this page.

Who wrote this paper?

Amanda C Miles, Jelena Vojicic, Paula Peyrani, Summer Rosenstock, H Li, Jeffrey Vietri, Yan Qi, Alison E. Randall, Xin Zhao, Wencheng Zhu, Bobby Zhao, Anan Zhou and 7 more.

What is the DOI of this paper?

10.1016/s1473-3099(26)00115-5, permanently at https://doi.org/10.1016/s1473-3099(26)00115-5. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 17 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.